Intellectual Property
RetinaPharma's technology is covered by one or more of the following patents. In addition, there are numerous international counterparts and patents pending.
The Company has exclusively licensed intellectual property from The Wilmer Eye Institute, Johns Hopkins University, the University of Toronto Innovations Foundation and certain corporate partners for use in a variety of fields.
Click on patent number for a link to the patent on www.delphion.com.
| Serial Number | Issued | Title |
|---|---|---|
| US 04,663,161 | 05/05/87 | Liposome methods and compositions |
| US 04,891,043 | 01/02/90 | System for Selective Release of Liposome Encapsulated Material via Laser Radiation |
| US 05,444,095 | 08/22/95 | Use of Deprenyl to Rescue Damaged Nerve Cells |
| US 05,767,164 | 06/16/98 | Use of Deprenyl to Rescue Damaged Nerve Cells |
| US 05,783,606 | 07/21/98 | Deprenyl Compounds for Treating Glaucoma |
| US 05,840,707 | 11/24/98 | Stabilizing and delivery means of biological molecules |
| US 05,844,003 | 12/01/98 | Use of Deprenyl Compounds to Maintain, Prevent Loss, or Recover Nerve Cell Function |
| US 05,935,942 | 08/10/99 | Selective and Non-Invasive Visualization or Treatment of Vasculature |
| US 05,981,598 | 11/09/99 | Deprenyl Compounds for Treatment of Glaucoma |
| US 05,994,318 | 11/30/99 | Cochleate delivery vehicles |
| US 06,083,161 | 07/04/00 | Apparatus and method for improved intraocular pressure determination |
| US 06,140,314 | 10/31/00 | Selective and Non-Invasive Visualization or Treatment of Vasculature |
| US 06,153,217 | 11/28/00 | Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
| US 06,248,727 | 06/19/01 | Selective and Non-Invasive Visualization or Treatment of Vasculature |
| US 06,440,950 | 08/27/02 | Selective and Non-Invasive Visualization or Treatment of Vasculature |
| US 06,455,590 B1 | 09/24/02 | Deprenyl Compounds for Treatment of Glaucoma |
| US 06,492,427 B1 | 12/10/02 | Methods of Treating Multiple Sclerosis |